Administrative Rules of Montana
Department 24 - LABOR AND INDUSTRY
Chapter 24.165 - BOARD OF OCCUPATIONAL THERAPY PRACTICE
Subchapter 24.165.5 - Licensing and Scope of Practice
Rule 24.165.521 - ANTISPASMODIC AGENTS PROTOCOLS

Universal Citation: MT Admin Rules 24.165.521

Current through Register Vol. 18, September 20, 2024

(1) Clinicians may use antispasmodic agents as directed by a licensed medical practitioner with prescriptive authority.

(2) Antispasmodic agents act by forming strong drug-receptor complex at postganglionic parasympathetic neuroeffector sites in smooth muscle, cardiac muscle and exocrine glands, thereby blocking action of acetycholine.

(3) Antispasmodic agents are indicated for reduction of the volume of perspiration by inhibiting sweat gland secretions to reduce muscle spasms and pain.

(4) Antispasmodic agents are contraindicated if the formulation contains sapphire, which can cause allergic reactions in susceptible individuals. Other contraindications may be listed in the current PDR.

(5) The antispasmodic agents permitted by this rule are:

(a) cyclobenzaprine 1 percent or 2 percent; and

(b) baclofen 10 percent.

AUTH: 37-24-201, 37-24-202, MCA IMP: 37-24-108, 37-24-109, MCA

Disclaimer: These regulations may not be the most recent version. Montana may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.